Medication for opioid use disorder in the Arab World: A systematic review

被引:3
|
作者
Alawa, Jude [1 ]
Muhammad, Muzzammil [2 ]
Kazemitabar, Maryam [3 ]
Bromberg, Daniel J. [4 ,5 ]
Garcia, Danilo [3 ]
Khoshnood, Kaveh [6 ]
Ghandour, Lilian [6 ]
机构
[1] Stanford Univ Sch Med, 291 Campus Dr, Stanford, CA 94305 USA
[2] Yale Univ Sch Med, 333 Cedar St, New Haven, CT 06510 USA
[3] Yale Univ Sch Publ Hlth, 60 Coll St, New Haven, CT 06510 USA
[4] Univ Gothenburg, Ctr Ethics Law & Mental Hlth CELAM, Box 100, S-40530 Gothenburg, Sweden
[5] Linkoping Univ, Dept Behav Sci & Learning, SE-58183 Linkoping, Sweden
[6] Amer Univ Beirut, Fac Hlth Sci, Dept Epidemiol & Populat Hlth, Dyck Bldg,POB 11-0236,Riad El Solh, Beirut 11072020, Lebanon
关键词
Opioid use disorder; Substance use; Medication for opioid use disorder; Opioid agonist therapy; Implementation science; Arab World; QUALITY-OF-LIFE; METHADONE-MAINTENANCE TREATMENT; SUBSTANCE USE DISORDER; SUBSTITUTION TREATMENT; RELAPSE PREVENTION; AGONIST TREATMENT; NORTH-AFRICA; MIDDLE-EAST; HEALTH; ADDICTION;
D O I
10.1016/j.drugpo.2022.103617
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Opioid use disorder (OUD) is a global public health concern. The standard of care for OUD involves treatment using medications such as buprenorphine, methadone, or naltrexone. No known review exists to assess the contextual factors associated with medication for opioid use disorder (MOUD) in the Arab World. This systematic review serves as an implementation science study to address this research gap and improve the uptake of MOUD in the Arab World.Methods: Systematic searches of Medline, PsycINFO, and EMBASE, and a citation analysis, were used to identify peer-reviewed articles with original data on MOUD in the Arab World. Quality assessment was conducted using the CASP appraisal tools, and main findings were extracted and coded according to the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework. Results: 652 research articles were identified, and 10 met inclusion criteria for final review. Four studies considered health-systems aspects of MOUD administration, such as cost-effectiveness, the motivations for and impact of national MOUD policies, the types of social, political, and scientific advocacy that led to the adoption of MOUD in Arab countries, and the challenges limiting its wide-scale adoption in the Arab World. Six papers considered MOUD at individual and group patient levels by evaluating patient quality of life, addiction severity, patient satisfaction, and patient perspectives on opioid agonist therapy.Conclusion: Despite financial and geographic barriers that limit access to MOUD in the Arab World, this review found MOUD to be cost-effective and associated with positive health outcomes for OUD patients in the Arab World. MOUD can be successfully established and scaled to the national level in the Arab context, and strong coalitions of health practitioners can lobby to establish MOUD programs in Arab countries. Still, the relative novelty of MOUD in this context precludes an abundance of research to address its long-term delivery in the Arab World.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Opioid use disorder in primary care PEER umbrella systematic review of systematic reviews
    Korownyk, Christina
    Perry, Danielle
    Ton, Joey
    Kolber, Michael R.
    Garrison, Scott
    Thomas, Betsy
    Allan, G. Michael
    Dugre, Nicolas
    Finley, Caitlin R.
    Ting, Rhonda
    Yang, Peter
    Vandermeer, Ben
    Lindblad, Adrienne J.
    CANADIAN FAMILY PHYSICIAN, 2019, 65 (05) : E194 - E206
  • [32] Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Mortality
    Brennan, Lawrence V.
    ANNALS OF INTERNAL MEDICINE, 2019, 170 (06) : 430 - 430
  • [33] Managing Acute Pain in Patients Taking Medication for Opioid Use Disorder: a Rapid Review
    Stephanie Veazie
    Katherine Mackey
    Kim Peterson
    Donald Bourne
    Journal of General Internal Medicine, 2020, 35 : 945 - 953
  • [34] Managing Acute Pain in Patients Taking Medication for Opioid Use Disorder: a Rapid Review
    Veazie, Stephanie
    Mackey, Katherine
    Peterson, Kim
    Bourne, Donald
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 3) : 945 - 953
  • [35] Medication-Assisted Treatment of Opioid Use Disorder: Review of the Evidence and Future Directions
    Connery, Hilary Smith
    HARVARD REVIEW OF PSYCHIATRY, 2015, 23 (02) : 63 - 75
  • [36] Incidence of buprenorphine-precipitated opioid withdrawal in adults with opioid use disorder: A systematic review
    Gregory, Caroline
    Yadav, Krishan
    Linders, Jordyn
    Sikora, Lindsey
    Eagles, Debra
    ADDICTION, 2025, 120 (01) : 7 - 20
  • [37] A Systematic Review and Meta-Analysis of Studies Evaluating the Effect of Medication Treatment for Opioid Use Disorder on Infectious Disease Outcomes
    McNamara, Katelyn F.
    Biondi, Breanne E.
    Hernandez-Ramirez, Raul U.
    Taweh, Noor
    Grimshaw, Alyssa A.
    Springer, Sandra A.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (08):
  • [38] Identifying patient-important outcomes in medication-assisted treatment for opioid use disorder patients: a systematic review protocol
    Sanger, Nitika
    Shahid, Hamnah
    Dennis, Brittany B.
    Hudson, Jackie
    Marsh, David
    Sanger, Stephanie
    Worster, Andrew
    Teed, Rand
    Rieb, Launette
    Tugwell, Peter
    Hutton, Brian
    Shea, Beverley
    Beaton, Dorcas
    Corace, Kimberly
    Rice, Danielle
    Maxwell, Lara
    Samaan, M. Constantine
    de Souza, Russell J.
    Thabane, Lehana
    Samaan, Zainab
    BMJ OPEN, 2018, 8 (12):
  • [39] Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021
    Jones, Christopher M.
    Han, Beth
    Baldwin, Grant T.
    Einstein, Emily B.
    Compton, Wilson M.
    JAMA NETWORK OPEN, 2023, 6 (08) : e2327488
  • [40] Medication-assisted treatment for opioid use disorder
    Kaplan, Louise
    NURSE PRACTITIONER, 2019, 44 (03): : 10 - 12